Drug & intervention

cholecalciferol

RxCUI 2418

Clinical trials36
Recruiting0
Related conditions20
Synonyms1

RxNorm ingredient and formulation relationships

Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.

Loading RxNorm relationships…
Background context

Cholecalciferol

Cholecalciferol, also known as vitamin D3, colecalciferol or calciol, is a skin-made vitamin D that is found in certain foods and used as a dietary supplement. It was first described in 1936, and is on the World Health Organization's List of Essential Medicines. In 2023, it was the 68th most commonly prescribed medication in the United States, with more than 9 million prescriptions, and is available as a generic medication. Cholecalciferol is synthesised in the skin following sunlight exposure. It is then converted in the liver to calcifediol (25-hydroxycholecalciferol D), which is further converted in the kidney to calcitriol (1,25-dihydroxycholecalciferol D). One of calcitriol's most important functions is to promote calcium uptake by the intestines. Cholecalciferol is present in food such as fatty fish, beef liver, eggs, and cheese. In some countries, cholecalciferol is also added to products like plants, cow milk, fruit juice, yogurt, and margarine. Cholecalciferol can be taken orally as a dietary supplement to prevent vitamin D deficiency or as a medication to treat associated diseases, including rickets. It is also used in the management of familial hypophosphatemia, hypoparathyroidism that is causing low blood calcium, and Fanconi syndrome. Vitamin-D supplements may not be effective in people with severe kidney disease. Excessive doses in humans can result in vomiting, constipation, muscle weakness, and confusion. Other risks include kidney stones. Doses greater than 40000 IU (1000 μg) per day are generally required before high blood calcium occurs. Normal doses,...

Background only. Canonical identity remains RxNorm; clinical-trial relationships come from ClinicalTrials.gov.

Clinical trials

36 shown
Effects Of Vitamin D On Bone, Muscle, And Adipose Tissue In Obese SubjectsNCT06508242 · 2023-04-28
UNKNOWN
Vitamin D and Painful Diabetic NeuropathyNCT05080530 · 2021-10-29
UNKNOWN
Vitamin D Supplementation in RNA-seq Profiles of Single-core Prostate Samples, Among VeteransNCT04621500 · 2019-06-04
COMPLETED
Pilot Study of OMEGA-3 and Vitamin D in High-Dose in Type I Diabetic PatientsNCT03406897 · 2018-07-23
COMPLETED
Blood Pressure in Blacks and Calcium (BBC) and Vitamin D StudyNCT03070483 · 2018-03-25
COMPLETED
Vitamin D Supplementation in Women With DCIS and/or LCISNCT02936999 · 2016-08-01
TERMINATED
The Significance of Vitamin D Storage in Adipose TissueNCT01728987 · 2016-08-01
WITHDRAWN
Can Vitamin D3 Improve Cognitive Function in Individuals With Type 2 Diabetes? (THINK-D)NCT02416193 · 2015-09-23
TERMINATED
Safety, Feasibility and Efficacy of Vitamin D Supplementation in Women With Metastatic Breast Cancer (SAFE-D)NCT02186015 · 2015-02-01
COMPLETED
The Link Between Obesity And Vitamin D in Bariatric Patients With Omega-loop Bypass SurgeryNCT02092376 · 2014-03-01
COMPLETED
Effects Vitamin D Suppletion on Postprandial Leukocyte ActivationNCT01967459 · 2013-10-01
COMPLETED
Vitamin D for Established Type 2 Diabetes (DDM2)NCT01736865 · 2012-12-01
COMPLETED
Vitamin D Treatment for Painful Diabetic NeuropathyNCT02737423 · 2012-06-01
COMPLETED
Vitamin D Supplementation and Regulatory FoxP3+ T Cells in the GUTNCT01538485 · 2012-01-01
COMPLETED
Dosage Calculation for Vitamin D TreatmentNCT02186106 · 2012-01-01
COMPLETED
Cholecalciferol and Genistein Before Surgery in Treating Patients With Early Stage Prostate CancerNCT01325311 · 2011-12-01
COMPLETED
Vitamin D and Prostate Cancer: A Clinical Study Enrolling Subjects Undergoing ProstatectomyNCT02726113 · 2011-10-01
COMPLETED
Vitamin D Supplementation on Cardiovascular Risk FactorsNCT01412710 · 2011-07-01
COMPLETED
Vitamin D and Staphylococcus Aureus in the Diabetes StudyNCT01395290 · 2011-04-01
COMPLETED
DAYLIGHT: Vitamin D Therapy in Individuals at High Risk of HypertensionNCT01240512 · 2010-12-01
COMPLETED
Effects of Vitamin D Supplementation in Subjects With New Onset of Type 1 DiabetesNCT01390480 · 2010-11-01
COMPLETED
Effect of Vitamin D Replacement During Winter Months in Patients With HypertensionNCT01166165 · 2010-07-01
COMPLETED
A Trial to Study the Effect of Long Term Vitamin D Supplementation on Insulin SensitivityNCT01052181 · 2010-01-01
COMPLETED
Effects of Vitamin D Supplementation in ObesityNCT01037140 · 2010-01-01
COMPLETED
Immune and Metabolic Effects of Vitamin D Supplementation in Healthy HumansNCT01248442 · 2009-11-01
COMPLETED
Diabetes Intervention Trial With Vitamin D in Subjects of Nordic and Sub-Indian EthnicityNCT00992797 · 2009-09-01
UNKNOWN
Vitamin D in Postmenopausal Women at High Risk for Breast CancerNCT00859651 · 2009-06-01
COMPLETED
Metabolic Effects of Vitamin D in Patients With Type 2 DiabetesNCT00812578 · 2008-12-01
COMPLETED
Changes in Breast Cancer Biomarkers Using Synergistic Prostaglandin InhibitorsNCT01425476 · 2008-07-01
COMPLETED
Vitamin D, C-reactive Protein and Insulin ResistanceNCT01019642 · 2008-03-01
COMPLETED
Vitamin D for the Prevention of Diabetes Type 2NCT00685594 · 2008-03-01
COMPLETED
Study of Vitamin D for Premenopausal Women at High Risk for Breast CancerNCT00976339 · 2007-09-01
COMPLETED
Randomized Controlled Trial of Neo-adjuvant Progesterone and Vitamin D3 in Women With Large Operable Breast Cancer and Locally Advanced Breast CancerNCT01608451 · 2007-09-01
TERMINATED
Characterization of Hyperparathyroidism and Vitamin D Deficiency in ObesityNCT00288873 · 2006-02-01
COMPLETED
Treatment of Obesity With Vitamin D (40.000 IE Per Week for 1 Year)NCT00243256 · 2005-11-01
COMPLETED
Study to Evaluate the Pharmacokinetics of Vitamin D (Cholecalciferol) in Patients Undergoing Obesity Surgery in a Deficit Situation and After StandardizationNCT01637155
UNKNOWN

Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.